Hepatitis B virus reactivation after effective sofosbuvir and ribavirin treatment in a patient with occult hepatitis B virus infection

被引：0

作者：

Odolini, Silvia ^{[1
,2
]}

Lanza, Paola ^{[1
,2
]}

Spinetti, Angiola ^{[1
,2
]}

Zaltron, Serena ^{[1
,2
]}

Urbinati, Lucia ^{[1
,2
]}

Vavassori, Andrea ^{[1
,2
]}

Nasta, Paola ^{[1
,2
]}

Festa, Elena ^{[1
,2
]}

Gargiulo, Franco ^{[3
]}

Rodella, Anna ^{[3
]}

Caruso, Arnaldo ^{[3
]}

Casari, Salvatore ^{[1
,2
]}

Castelli, Francesco ^{[1
,2
]}

Vigano, Mauro ^{[4
]}

机构：

[1] Univ Brescia, Clin Infect & Trop Dis, Brescia, Italy

[2] Spedali Civil Brescia, Gen Hosp, Brescia, Italy

[3] Brescia Spedali Civili, Lab Microbiol, Gen Hosp, Brescia, Italy

[4] Univ Milan, Hepatol Unit, Osped San Giuseppe, Milan, Italy

来源：

NEW MICROBIOLOGICA | 2017年 / 40卷 / 03期

关键词：

Reactivation; DAAs; HCV; Occult B hepatitis; C-VIRUS; COINFECTION; THERAPY;

D O I：

暂无

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Reactivation of the hepatitis B virus (HBV) has been reported in patients with occult infection (OBI), i. e. HBV surface antigen (HBsAg) negative, HBV core antibody (anti-HBc) positive +/- antibodies against HBsAg (anti-HBs) and detectable HBV DNA in serum or liver, receiving immunosuppressive or cytotoxic therapies. Recently, concerns have been raised regarding the risk of HBV reactivation in OBI patients treated with direct acting antiviral agents (DAAs) for chronic hepatitis C (CHC). Here we describe a case of HBV reactivation in a 72-year-old woman with OBI as a possible consequence of effective treatment with sofosbuvir (SOF) and ribavirin (Rbv) for genotype 2a/2c CHC.

引用

页码：218 / 220

页数：3

共 50 条

[1] Hepatitis B virus reactivation after successful treatment of hepatitis C virus with sofosbuvir and ribavirin A case report and literature review
Miyasaka, Akio
Yoshida, Yuichi
Suzuki, Akiko
Masuda, Tomoyuki
Okamoto, Hiroaki
Takikawa, Yasuhiro
MEDICINE, 2020, 99 (41) : E22650
[2] Reactivation of Hepatitis B Virus During Treatment of Hepatitis C Genotype 3 with Daclatasvir and Sofosbuvir in a Patient with Dual Infection of Hepatitis B and Hepatitis C Virus
Zacharakis, Georgios
Alzahrani, Jaman
HEPATITIS MONTHLY, 2018, 18 (01)
[3] Hepatitis B reactivation following treatment with abatacept in a patient with past hepatitis B virus infection
Fanouriakis, Antonis
Vassilopoulos, Dimitrios
Repa, Argyro
Boumpas, Dimitrios T.
Sidiropoulos, Prodromos
RHEUMATOLOGY, 2014, 53 (01) : 195 - 196
[4] Therapy of Occult Hepatitis B Virus Infection and Prevention of Reactivation
Raimondo, Giovanni
Filomia, Roberto
Maimone, Sergio
INTERVIROLOGY, 2014, 57 (3-4) : 189 - 195
[5] Hepatitis B Virus Reactivation During Successful Treatment of Hepatitis C Virus With Sofosbuvir and Simeprevir
Collins, Jeffrey M.
Raphael, Kara Loren
Terry, Charles
Cartwright, Emily J.
Pillai, Anjana
Anania, Frank A.
Farley, Monica M.
CLINICAL INFECTIOUS DISEASES, 2015, 61 (08) : 1304 - 1306
[6] Hepatitis B virus reactivation in seronegative occult hepatitis B patient receiving ibrutinib therapy
Lam, Lok-Ka
Chan, Thomas Sau Yan
Hwang, Yu-Yan
Mak, Lung-Yi
Seto, Wai-Kay
Kwong, Yok-Lam
Yuen, Man-Fung
VIROLOGY JOURNAL, 2023, 20 (01)
[7] Hepatitis B virus reactivation in seronegative occult hepatitis B patient receiving ibrutinib therapy
Lok-Ka Lam
Thomas Sau Yan Chan
Yu-Yan Hwang
Lung-Yi Mak
Wai-Kay Seto
Yok-Lam Kwong
Man-Fung Yuen
Virology Journal, 20
[8] Reactivation of hepatitis virus B infection in a patient with rheumatoid arthritis after treatment with rituximab
Carlos Salman-Monte, Tarek
Pilar Lisbona, Maria
Garcia-Retortillo, Montserrat
Maymo, Joan
REUMATOLOGIA CLINICA, 2014, 10 (03): : 196 - 197
[9] Occult hepatitis B virus infection
Allain, JP
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2004, 11 (01) : 18 - 25
[10] Occult hepatitis B virus infection
Raimondo, Giovanni
Pollicino, Teresa
Cacciola, Irene
Squadrito, Giovanni
JOURNAL OF HEPATOLOGY, 2007, 46 (01) : 160 - 170

← 1 2 3 4 5 →